EUVIMEDEUVIMED entdecken
Crossref

RENOUVELLEMENT ET ADAPTATION DES PRESCRIPTIONS PAR LE PHARMACIEN HOSPITALIER EN ONCOLOGIE MEDICALE: MISE EN ŒUVRE ET EVALUATION

Wala Ammor, Pierre Nizet, Siméon Robin, Jean-François Huon

Annales Pharmaceutiques Françaises · 2026

DOI: 10.1016/j.pharma.2026.02.013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annales Pharmaceutiques Françaises, 2026. Verfasst von Wala Ammor und 3 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacie, CHU de Nantes, Nantes Université, 1, place Alexis-Ricordeau, 44000 Nantes, France. Electronic address: wala.ammor@chu-nantes.fr. Hauptthemen laut MEDLINE: Pharmacists, Pharmacy Service, Hospital, Medical Oncology, Drug Prescriptions.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: The decree of 21 February 2023 introduced prescription renewal and adaptation (RAP) by hospital pharmacists to improve the continuity and safety. The aim of this prospective descriptive study was to evaluate the implementation of RAP in medical oncology at Nantes University Hospital. MATERIALS AND METHOD: The study was conducted over 50days period between June and August 2025 among hospitalised patients receiving clinical pharmacy services. The data collected focused on the type and volume of RAP and their follow-up on day 3. Semi-structured individual interviews with oncologists were conducted to explore their perceptions and experiences of the system. RESULTS: A total of 334 RAP were carried out in 57 patients: 290 direct renewals (86.8%), 33 direct adaptations (9.9%) and 11 concerted adaptations (3.3%). On day 3, 98% of renewals and 91% of adaptations were maintained. Oncologists considered the system to be safe, while emphasising the importance of clear traceability and interprofessional collaboration. DISCUSSION: These findings suggest that RAP can play a key role in ensuring the safety and optimisation of medication management in oncology patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PharmacistsPharmacy Service, HospitalMedical OncologyDrug PrescriptionsHumansProspective StudiesFemaleAntineoplastic AgentsMaleMiddle Aged

Stichwörter der Autor:innen

Clinical pharmacyCollaboration interprofessionnelleInterprofessional collaborationMedical oncologyMedication safetyOncologie médicalePharmacie cliniquePrescription renewal and adaptationRenouvellement et adaptation des prescriptionsSécurité médicamenteuse

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Pharmacie, CHU de Nantes, Nantes Université, 1, place Alexis-Ricordeau, 44000 Nantes, France. Electronic address: wala.ammor@chu-nantes.fr.
  • Pharmacie, CHU de Nantes, Nantes Université, 1, place Alexis-Ricordeau, 44000 Nantes, France.

Zitieren

APA

Ammor, W., Nizet, P., Robin, S., & Huon, J. F. (2026). RENOUVELLEMENT ET ADAPTATION DES PRESCRIPTIONS PAR LE PHARMACIEN HOSPITALIER EN ONCOLOGIE MEDICALE: MISE EN ŒUVRE ET EVALUATION. Annales Pharmaceutiques Françaises. https://doi.org/10.1016/j.pharma.2026.02.013

Vancouver

Ammor W, Nizet P, Robin S, Huon JF. RENOUVELLEMENT ET ADAPTATION DES PRESCRIPTIONS PAR LE PHARMACIEN HOSPITALIER EN ONCOLOGIE MEDICALE: MISE EN ŒUVRE ET EVALUATION. Annales Pharmaceutiques Françaises. 2026. doi:10.1016/j.pharma.2026.02.013

BibTeX
@article{Ammor2026,
  author = {Ammor, Wala and Nizet, Pierre and Robin, Siméon and Huon, Jean-François},
  title = {RENOUVELLEMENT ET ADAPTATION DES PRESCRIPTIONS PAR LE PHARMACIEN HOSPITALIER EN ONCOLOGIE MEDICALE: MISE EN ŒUVRE ET EVALUATION},
  journal = {Annales Pharmaceutiques Françaises},
  year = {2026},
  doi = {10.1016/j.pharma.2026.02.013}
}
Kostenlos starten →